Already have an account?


Login with an existing Projects In Knowledge account Log in with your MPT account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy


  • Multiple Sclerosis — Case Study: Immune Reconstitution Therapy in Relapsing Multiple Sclerosis – @Point of Care Chapter
  • Immune reconstitution represents a relatively new approach to the treatment of relapsing multiple sclerosis (MS) patients. This case study follows a young patient with aggressive relapsing MS. He continued to have relapses after injectable and oral disease-modifying treatments were tried, and opted for immune ... more >>
    A. Cross, MD
  • Psychiatric Disorders — Case Study: Maintenance Treatment for Bipolar I Disorder – @Point of Care Chapter
  • This activity describes a real-life case scenario of a patient with longstanding bipolar I disorder who reports difficulty maintaining adherence to her daily medications and has recently experienced a relapse. Because medication adherence is critically important to maintenance of euthymia in patients with ... more >>
    C. Baldassano, MD
  • Psychiatric Disorders — Case Study: Initial Diagnosis and Treatment of an Individual With Bipolar I Disorder – @Point of Care Chapter
  • Bipolar disorder is often initially mistaken for unipolar depression. Several factors should increase suspicion of bipolarity in a patient experiencing acute depression. This case of a 19-year-old male presenting with depression illustrates these factors. In addition, this case covers the treatment of a ... more >>
    M. Thase, MD
  • Multiple Sclerosis — Immune Reconstitution vs Maintenance Therapy: Long-Term Remission as a Therapeutic Target – @Point of Care Chapter
  • Recent years have seen a proliferation of new treatment options for patients with multiple sclerosis (MS). These treatments can broadly be classified by mechanism of action and dosing schedule into maintenance treatments (which require continuous therapy) and immune reconstitution therapies (IRTs), often ... more >>
    G. Giovannoni, MBBCh, PhD
  • Multiple Sclerosis — Clinical Advances in Immune Reconstitution Therapies in Multiple Sclerosis – @Point of Care Chapter
  • Immune reconstitution therapies (IRTs), or induction therapies, are high-efficacy treatments given as a short course to "reset" the immune system of patients with multiple sclerosis (MS). Join Dr. Thomas Leist as he discusses the clinical trials efficacy results and safety considerations of the MS IRTs, along ... more >>
    T. Leist, MD, PhD
  • Multiple Sclerosis — Individualizing Strategies for Switching and Sequencing Therapy in Patients With MS – @Point of Care Chapter
  • Optimal treatment for a patient with multiple sclerosis (MS) involves early initiation of treatment, selecting a treatment of appropriate potency given the patient's disease activity level, assessing for suboptimal response, and switching therapy as needed. Dr. Patricia K. Coyle reviews current concepts about ... more >>
    P. Coyle, MD
  • Multiple Sclerosis — MS Diagnosis and Classification – @Point of Care Chapter
  • Using the latest McDonald criteria, diagnosis of multiple sclerosis (MS) is now simpler and faster than it was a few years ago. This activity discusses how to apply the current McDonald criteria in clinical practice and how to make the best use of diagnostic tools, such as imaging, cerebrospinal fluid ... more >>
    K. Costello, MS, ANP-BC, MSCN
  • Multiple Sclerosis — Treatments in Development for Multiple Sclerosis – @Point of Care Chapter
  • There have been major advancements in the treatment of multiple sclerosis (MS) in recent years, but there is not a cure, and many patients fail to respond to currently available therapies because of lack of efficacy, adverse effects, or poor tolerability. For many patients, a novel, effective oral therapy ... more >>
    P. Coyle, MD
  • Multiple Sclerosis — Currently Available Treatments for Multiple Sclerosis – @Point of Care Chapter
  • There is a range of medications available for patients with multiple sclerosis (MS). It is important to understand which treatments are available for patients in different phases of the disease. This activity begins by discussing the clinical course of MS. The focus then transitions to current therapies for ... more >>
    P. Coyle, MD
  • Hypoparathyroidism — Diagnosis and Prognosis of Hypoparathyroidism – @Point of Care Chapter
  • Accurate diagnosis of hypoparathyroidism is essential for planning a targeted treatment approach for the individual patient. If the diagnosis is missed, patients may experience debilitating symptoms for months or even years. In this chapter, Dr. Bart L. Clarke focuses on the risk factors and signs and ... more >>
    B. Clarke, MD
  • State of the Science: Multiple Sclerosis Innovations
  • State of the Science: Multiple Sclerosis Innovations provides comprehensive and up-to-date best practices in multiple sclerosis management. This includes innovative webcasts derived from major scientific conferences synthesized for the practicing clinician, interactive practice-based cases, and articles from ... more >>
    A. Cross, MD
    P. Peck, Editor-in-Chief
  • Master Class: Chronic Lymphocytic Leukemia
  • Master Class: Chronic Lymphocytic Leukemia (CLL) is designed to highlight relevant, practical advances in the treatment of CLL using a modular structure to provide an in-depth review of best practices with multiple complementary activities, including video webcasts with expert clinical specialists, case ... more >>
    B. Cheson, MD, FACP, FAAAS
  • The Art & Science of Heart Failure Management
  • The Art & Science of Heart Failure Management is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in heart failure ... more >>
    J. Udelson, MD
  • Pulmonology Mastery in COPD
  • Pulmonology Mastery in COPD is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in COPD. The curriculum includes ... more >>
    B. Make, MD
  • Mastery of Medicine in Diabetes Management
  • Mastery of Medicine in Diabetes Management is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in diabetes ... more >>
    V. Fonseca, MD, FRCP
  • Clinical Context: Stroke Prevention in Atrial Fibrilation
  • Clinical Context: Stroke Prevention in
    Atrial Fibrillation
    is designed to provide up-to-date information on patient identification, risk factors, and current and emerging treatments and best practices in the management of atrial fibrillation.

    The curriculum includes:
    • 6 case studies
    • MedPage Today meeting
    ...
    more >>
    C. Yancy, MD, MSc
  • Hematology Mastery in Multiple Myeloma
  • Hematology Mastery in Multiple Myeloma is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple myeloma. ... more >>
    N. Raje, MD
  • Rheumatology Mastery in Rheumatoid Arthritis
  • Rheumatology Mastery in Rheumatoid Arthritis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in rheumatoid ... more >>
    M. Husni, MD, MPH
  • Neurology Mastery in Multiple Sclerosis
  • Neurology Mastery in Multiple Sclerosis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple sclerosis. ... more >>
    J. Bowen, MD
  • Rheumatology Mastery In Ankylosing Spondylitis
  • Rheumatology Mastery in Ankylosing Spondylitis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in ankylosing ... more >>
    J. Reveille, MD
  • Pulmonary Arterial Hypertension @Point of Care
  • Pulmonary arterial hypertension (PAH) is a rare disorder associated with significant morbidity and mortality. Three PAH treatment pathways or targets have been identified—the endothelin pathway, the nitric oxide pathway, and the prostacyclin pathway. In 1995 the FDA approved the first treatment specifically ... more >>
    R. Channick, MD
  • Bipolar Disorder @Point of Care
  • Bipolar disorder is a common mental illness that can have a devastating impact on people’s lives without effective treatment. Important developments in the understanding of bipolar disorder and its treatment have occurred in the past few years, with several new medications and formulations developed and ... more >>
    M. Thase, MD
  • Classical Hodgkin Lymphoma @Point of Care
  • Classical Hodgkin lymphoma (CHL) has a high cure rate with available therapies - nearly 90% - yet advances continue to be made to individualize therapy, minimize the risk of late toxicity, and expand therapeutic options. Current first-line treatment strategies for patients with early- and advanced-stage CHL ... more >>
    C. Moskowitz, MD
  • Nontuberculous Mycobacterial Lung Disease @Point of Care
  • Nontuberculous mycobacterial (NTM) lung disease, a condition of progressive lung damage caused by mycobacterial species other than those that cause tuberculosis or leprosy, is occurring with increasing frequency in the United States. Characterized by difficulties in diagnosis, non-FDA-approved treatment ... more >>
    N. Schluger, MD
  • Alzheimer's Disease @Point of Care
  • This @Point of Care is a comprehensive, continually updated resource developed to enhance compliance to established clinical guidelines to improve screening and timely diagnosis of Alzheimer’s disease (AD) and to support current best practices of managing the symptoms of AD.
    R. Turner, MD, PhD
  • Immuno-Oncology @Point of Care: A Focus on Head and Neck Cancer
  • Primary and adjunctive treatment approaches for patients with head and neck squamous cell carcinoma are complex to navigate, requiring assessment of patient-specific risk factors, knowledge of treatment recommendations, and input from a multispecialty team. Furthermore, these patients typically have poor ... more >>
    R. Ferris, MD, PhD
  • Atopic Dermatitis @Point of Care
  • Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, and recent advances in the understanding of the immune and inflammatory processes involved in AD pathogenesis have led to the development and approval of novel therapies for the treatment of this disease. With ... more >>
    L. Eichenfield, M.D.
  • Hypercholesterolemia @Point of Care
  • The Hypercholesterolemia @Point of Care platform provides comprehensive and current information organized into a progressive series of activities and patient cases covering guideline-recommended diagnostic and treatment strategies with up-to-date clinical trial data and insights from top specialists. ... more >>
    M. Miller, MD
  • Rheumatologic Diseases @Point of Care: Ankylosing Spondylitis
  • Axial spondyloarthritis (axSpA) is a chronic rheumatic disorder, comprised of a disease spectrum that ranges from nonradiographic disease to radiographic axSpA, also known as ankylosing spondylitis (AS). As early treatment can reduce disease progression and burden, it is essential that patients be accurately ... more >>
    V. Strand, MD, MACR, FACP
  • Lung Cancer — Ask the Expert: Lung Cancer – Webcast
  • Patients diagnosed with non-small cell lung cancer and small cell lung cancer now have treatment options beyond traditional chemotherapy. Checkpoint inhibitors, including the programmed cell death 1 (PD-1) inhibitors nivolumab and pembrolizumab, and the programmed cell death ligand 1 (PD-L1) inhibitors ... more >>
    T. Stinchcombe, MD
  • Multiple Sclerosis — Practice Guidelines: Disease-Modifying Therapies for Adults with MS – Webcast
  • There have been many advances in the understanding of multiple sclerosis (MS) since the publication of the last guidelines on disease modifying therapies (DMTs) in 2002, with approval of many new therapies, re-evaluation of the classification of MS in 2014, and revision of the McDonald diagnostic criteria in ... more >>
    F. Lublin, MD
  • Pulmonology — Approaches to Managing Persistent Uncontrolled Asthma, A Video Roundtable – Video Presentation
  • The management of asthma continues to present a significant clinical challenge, with a trend towards worsening uncontrolled asthma in children. The challenges to treatment of asthma were addressed in a number of presentations at the American Thoracic Society 2018 conference, and will be discussed in this ... more >>
    P. Peck, Editor-in-Chief
    M. Wechsler, MD, MMSc
  • Multiple Sclerosis — Innovations in Managing Immune Dysfunction in Patients with Multiple Sclerosis - ACTRIMS 2018 Webcast – Webcast
  • Multiple sclerosis (MS) is a chronic immune-mediated inflammatory and neurodegenerative disorder. Advances in our understanding of MS immunopathology have led to the identification of new therapeutic targets and the development of new therapies, with 16 disease-modifying therapies currently available and ... more >>
    T. Leist, MD, PhD
  • Uterine Fibroids — Strategies for Relief: New Approaches to Uterine Fibroids Clinical Highlights from Live Meeting – October 2017
  • Significant progress has recently been made in the management of uterine fibroids, including the development of minimally invasive procedures, fertility-sparing techniques, and pharmacologic options that hold substantial promise to improve morbidity, symptom severity, and quality of life for women with ... more >>
    A. Al-Hendy, MD, PhD
    W. Catherino, MD, PhD
  • Cardiovascular/Diabetes — Cardiovascular Challenges in Diabetes – Video Presentation
  • Although the association between the incidence of diabetes and that of heart failure is well known, the advent of new diabetic therapies now presents an opportunity to modify this interaction, thereby potentially improving outcomes. Join Drs. James Januzzi, Javed Butler, Christopher P. Cannon, Mikhail ... more >>
    J. Januzzi, MD
  • Multiple Sclerosis — Improving the Management of Walking Impairment and Foot Drop in MS – Webcast
  • Almost two-thirds of MS patients report significant difficulty in walking. Yet, approximately 40% of patients with MS rarely or never discuss this problem with their physicians. As a result of this gap in communication, many MS patients do not experience the benefits of available pharmacologic and ... more >>
    A. Goodman, MD
  • Multiple Sclerosis — How Can We Better Manage MS Patients Today? – Webcast
  • As in the case of other chronic diseases for which treatment slows disease progression but does not provide a cure, maintaining treatment adherence over the long term is a challenge for patients with MS and their physicians. Determining treatment with both clinical outcomes and adherence in mind is ... more >>
    D. Goodin, MD
  • Multiple Sclerosis — Multiple Sclerosis Resource Network - Professional Social Network and Resource for Clinicians – Web Forum
  • The MS Resource Network serves as home to an interactive MS regional community that allows you to communicate with your local peers. Use the Members and Forum links, email function, or join a Group to connect with other clinicians and participate in MS-related discussions. The more you participate and ... more >>
  • AMD — Practice Management Update: 2007 and Beyond—Changes in AMD Management – Audio with Slides
  • This free CME/CE webcast for physicians, nurses, and practice managers presents updated information about current and emerging therapies for age-related macular degeneration (AMD), including agents that target vascular endothelial growth factor. Changes in Medicare reimbursement guidelines for 2007 and beyond ... more >>
  • Multiple Sclerosis — MS Innovations: Management of an RRMS Patient With Breakthrough Disease – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with relapsing-remitting multiple sclerosis (RRMS) who has breakthrough disease on his first disease-modifying therapy (DMT). It highlights the importance of monitoring for suboptimal response to therapy, treatment options available for ... more >>
    J. Bowen, MD
  • Multiple Sclerosis — MS Innovations: RRMS Patient Worsens and Receives a New Diagnosis of SPMS – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with relapsing multiple sclerosis (MS) who has breakthrough disease on two disease-modifying therapies (DMTs), then develops symptoms of secondary-progressive MS (SPMS). It highlights considerations for monitoring for disease breakthrough, ... more >>
    P. Coyle, MD
  • Leukemia — Case Study: Initiation of First-Line Treatment in Patient With Symptomatic CLL and del(17p)/TP53 Mutation – Case Study
  • In this master class, Dr. William Wierda discusses a 64-year-old male patient with untreated chronic lymphocytic leukemia who developed leukocytosis, became symptomatic, and needed treatment. The case considers the initial evaluation and diagnosis of this patient, including his immunologic and genetic profile ... more >>
    W. Wierda, MD, PhD
  • Leukemia — Case Study: Achieving Durable Response After Progression on Ibrutinib – Case Study
  • Ibrutinib has improved survival for patients with relapsed, high-risk chronic lymphocytic leukemia, but patients who relapse after ibrutinib pose a challenging clinical scenario. This case study reviews the efficacy and safety data on treatment options to achieve a durable response in a 74-year-old man who ... more >>
    A. Mato, MD, MSCE
    L. Roeker, MD, MSCE
  • Leukemia — Case Study: Optimizing CLL Management: Venetoclax Dosing and TLS Prophylaxis – Case Study
  • Small-molecule inhibitors have improved outcomes for patients with del(17p)-positive chronic lymphocytic leukemia (CLL), a population with a historically poor prognosis, yet they do pose potentially serious risks. This case study reviews the efficacy and safety data of treatment options for a 78-year-old man ... more >>
    B. Cheson, MD, FACP, FAAAS
    M. Yazdy, MD
  • Heart Failure — Managing a Hispanic Patient With Diabetes, High Cholesterol, and Heart Failure With Reduced Ejection Fraction – Case Study
  • This case demonstrates the real-life clinical scenario of the initial presentation of a patient with heart failure and comorbidities. It demonstrates guideline- and evidence-based diagnosis and treatment of such patients, with emphasis on the need for early initiation of treatment in order to prevent or ... more >>
    Y. Selektor, MD
  • Heart Failure — Managing an Elderly Heart Failure Patient With Hypertension – Case Study
  • This case discusses the real-life clinical scenario of an elderly patient with hypertension and symptoms of heart failure (HF), and describes the common progression of hypertension to HF with advancing age. The case emphasizes evidence-based treatment, as multiple therapies have been shown to be effective for ... more >>
    M. Dunlap, MD
  • Multiple Sclerosis — RRMS Patient With Preference for Oral Medications – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with relapsing multiple sclerosis who develops intolerance to injections and has breakthrough disease activity on interferon treatment. It highlights considerations for patients who prefer oral disease-modifying treatments, including ... more >>
    J. Rinker, MD
  • Multiple Sclerosis — Managing a Relapsing MS Patient With Active Disease – Case Study
  • Some patients with relapsing multiple sclerosis (MS) may have very active disease with multiple clinical and radiologic relapses despite compliance with their disease-modifying therapy. This case demonstrates the real-life clinical scenario of a male with relapsing MS who suffers multiple relapses on his ... more >>
    S. Chahin, MD, MSCE
  • Heart Failure — Managing a Heart Failure Patient With Cardiovascular Disease – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with diabetes and hypertension, illustrating the work-up and diagnosis of her cardiovascular disease and heart failure. The case also highlights the guideline-recommended strategies for the treatment and subsequent optimization of medical ... more >>
    E. Hsich, MD